Qiang Su (Su et al., 2019) concluded that compared with chemotherapy, PD-1/PD-L1 inhibitors showed significant increase in grade 1–5 and grade 3–5 pneumonitis, which was consistent with the results of ours. This evidence concerns the gene CD274 and pneumonitis.